CD4 and COVID-19: About 20-60% of COVID-19-naïve individuals have circulating CD4+ T cells that can cross-recognize SARS-CoV-2 spike and nonspike antigens, what brings important implications for SARS-CoV-2 primary infection and vaccination (73, 80).